fibroblast growth factor 8
| GO Term | Evidence Code | PMID |
|---|---|---|
| MAPK cascade |
|
|
| branching involved in blood vessel morphogenesis |
|
|
| metanephros development |
|
|
| branching involved in ureteric bud morphogenesis |
|
|
| organ induction |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| obsolete extracellular space |
|
|
| cytoplasm |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| type 1 fibroblast growth factor receptor binding |
|
|
| type 1 fibroblast growth factor receptor binding |
|
|
| type 2 fibroblast growth factor receptor binding |
|
|
| type 2 fibroblast growth factor receptor binding |
|
|
| growth factor activity |
|
| InterPro |
|---|
| Cytokine IL1/FGF |
| Fibroblast growth factor family |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:11198 | DiGeorge syndrome | |
| DOID:6419 | tetralogy of Fallot |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026